Stuttgart, April 2026 – Thieme and Certara, Inc (Nasdaq: CERT) today announced the integration of Marvin with chemical databases, Science of Synthesis and Pharmaceutical Substances. Integrating the latest version of Marvin from Certara’s Chemaxon portfolio makes drawing chemical structures and reactions to find matches in the databases faster, more accurate and user-friendly.
Chemaxon, now part of the discovery software and services portfolio of Certara, develops cutting-edge scientific informatics software products used by the life sciences industry for research and development. Marvin, the portfolio’s web-based chemical drawing software, can easily be integrated into chemical databases and other chemistry software.
“Using multiple applications to draw compounds and calculate chemical properties is cumbersome and slows down scientific work. Marvin was developed as an all-in-one chemical sketcher to streamline these tasks, allowing chemists to spend less time drawing and more time driving scientific breakthroughs,” said Luca Szabó, Product Manager Marvin, Chemaxon.
Thieme, a leading provider of information and services that contribute to the improvement of health and healthcare, is committed to delivering key information to life sciences professionals at the right time and in the right place. Discovering effective, practical experimental procedures that can be implemented quickly in the lab is central to chemists' day-to-day work. With up-to-date information, chemists can begin designing and planning syntheses immediately.
A flexible, easy-to-use drawing tool with name-to-structure conversion is essential for chemical-reaction databases such as Science of Synthesis and Pharmaceutical Substances. Science of Synthesis provides full-text descriptions of organic transformations and synthetic methods as well as experimental procedures. It is a unique chemical information tool with insightful didactic reviews by experts that add real value to synthesis planning. Pharmaceutical Substances is an online tool that presents chemical structures and detailed synthetic routes, including starting materials and intermediates – for all significant APIs. All information is extracted from patent literature compiled by experienced experts in medicinal and pharmaceutical chemistry.
"We were pleased with the smooth migration: no development was required for the backend, and switching the frontend from the legacy Marvin JS to the new Marvin took only minimal developer time," said Dr. Alex Russell, Product Manager Chemistry Databases at Thieme Group. "The Chemaxon team is constantly working to simplify the integration process, enabling us to provide our users with improved tools while causing minimal disruption."